what is tirzepatide sublingual for Weight Loss Strive now has oral Tirzepatide

Tirzepatide drives aggressive fat loss through dual GLP-1 and GIP receptor activation, producing 15-22% average weight loss in clinical trials

Tirzepatide is patent-protected

Is your mouth clean and appropriately moist when you dose

Standard blood panels, including the basic metabolic panel (BMP), comprehensive metabolic panel (CMP), complete blood count (CBC), and lipid panels , are not designed to detect peptide-based medications

Instead of standard dosing protocols, the GLP-1 ID model uses individualized virtual integrative medicine (IVIM) to personalize your treatment based on your unique response, tolerance, and goals